Last reviewed · How we verify
Fluorescite
At a glance
| Generic name | Fluorescite |
|---|---|
| Also known as | fluorescein sodium |
| Sponsor | Aditya Kaza |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Novel Intraoperative Fluorescence-guided System for Evaluating Margins During Breast-conserving Surgery for Breast Cancer (NA)
- Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction (PHASE4)
- Tunlametinib Combination Therapy in KRAS-Mutated Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancer (PHASE2)
- Automated Applanation Tonometry - Updated (NA)
- Retinal Vessel Leakage in Cerebral Small Vessel Disease
- Neoadjuvant Tebentafusp for Uveal Melanoma (PHASE2)
- Prevention of Onset and Transition to an Advanced Form of Diabetic Retinopathy in Children (NA)
- Intraoperative Use of I.V. Sodium Fluorescein in Suspected CNS Tumors
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |